Delivery Order SPE2DB22D3016-SPE2DB25FAWP2
- Not listed
- The Defense Logistics Agency awarded a $3,582.76 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of RECOTHROM under a firm fixed price contract, with an ultimate completion date of July 21, 2025. This is a non-set-aside award issued on July 18, 2025, with performance to be completed in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 5,000 unit vials of Recothrom, a pharmaceutical product used in surgical hemostasis. This firm fixed-price delivery order, valued at $2,567.33, was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $16,136.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a topical thrombin product used in surgical hemostasis. Issued on August 22, 2025, with an ultimate completion date of August 25, 2025, this non-set-aside contract represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC SPE2DX) valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,631 to Amerisourcebergen Drug Corporation for 20,000 units of Recothrom vials. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications, with a firm fixed price ceiling value of $6,998.20. The award, executed on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside contract. The contract will be fulfilled from AmerisourceBergen's operations in...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 23, 2025, by the Defense Logistics Agency Medical Supply Chain to supply 20,000 unit vials of RECOTHROM (thrombin topical) with a ceiling value of $9,422.34. This non-competitive, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is set to be completed by July 24,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $1,793.32, was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for 20,000 unit vials of Recothrom (thrombin topical), a hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $7,567.75, was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical procedures. This firm fixed-price delivery order, valued at $4,839.49, represents a competitive award with no set-aside designation and is scheduled for completion by August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- This federal contract award is a delivery order worth $6,184.71 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 20,000 unit vials of the product RECOTHROM. The award has an ultimate completion date of November 12, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAWP2Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,032.07 for 20,000 unit vials of RECOTHROM on May 15, 2025, with an ultimate completion date of May 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as the company's primary mechanism for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for the Defense Logistics Agency's medical supply chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for RECOTHROM vials represents one of numerous competitively awarded transactions the contractor fulfills through its master IDC, demonstrating its capability to meet federal procurement requirements and support military healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 5/15/25 |